Northwestern University: Pancreatic Neoplasms trials
The registry lists 10 Pancreatic Neoplasms studies with Northwestern University as lead sponsor. 3 are open to participants now and 2 have results posted.
Phase 1 5Phase 2 6No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP DeletionRecruitingNCT07594626Phase 1/2
- CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid TumorsRecruitingNCT05733000Phase 2
- Evaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant ChemotherapyRecruitingNCT04616131
- Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic CancerTerminatedNCT03723915Phase 2Results posted
- Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT01473940Phase 1Results posted
- Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic CancerCompletedNCT00460174Phase 2
- Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic CancerTerminatedNCT00281996Phase 1
- Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal ObstructionCompletedNCT00004910Phase 1/2
- Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by SurgeryCompletedNCT00004895Phase 2
- Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00004095Phase 1